连续性肾脏替代疗法对尿毒症脑病患者中分子毒素的清除效果分析.docVIP

连续性肾脏替代疗法对尿毒症脑病患者中分子毒素的清除效果分析.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
连续性肾脏替代疗法对尿毒症脑病患者中分子毒素的清除效果分析   [摘要] 目的 研究连续性肾脏替代疗法对尿毒症脑病患者中分子毒素的清除效果。方法 随机抽取2013年8月―2015年1月该院收治的尿毒症脑病患者62例,按照随机数字表法随机分为对照组(n=30)和观察组(n=32),所有患者均进行基础对症治疗,对照组给予普通血液透析治疗,观察组进行连续性静脉-静脉血液滤过治疗,持续治疗2周后观察对比两组患者治疗效果,并比较中分子毒素清除效果。 结果 观察组有效率93.8%显著高于对照组73.3%,差异有统计学意义(χ2=4.77,P0.05);两组患者透析治疗后PTH、β2MG、BUN、Scr水平均显著下降,差异有统计学意义(P0.05);观察组治疗后PTH、β2MG、BUN、Scr水平显著低于对照组,差异有统计学意义(P0.05)。 结论 采用连续性肾脏替代疗法能有效清除尿毒症脑病患者中分子毒素,临床效果好,值得推广。   [关键词] 连续性肾脏替代疗法;尿毒症脑病;中分子毒素   [中图分类号] R5 [文献标识码] A [文章编号] 1674-0742(2015)11(b)-0001-02   [Abstract] Objective To study the effect of continuous renal replacement therapy on the removal of middle molecular toxins in patients with uremic encephalopathy. Methods 62 patients with uremic encephalopathy admitted into the hospital during August 2013 to January 2015 were selected and randomly divided to the control group (n=30) and the observation group (n=32) according to the random number table method. All the patients received primary symptomatic treatment. The control group were given common hemodialysis therapy while the observation group were treated with continuous veno-venous hemofiltration. The curative effect of the two groups were observed and compared after 2 weeks of continuous treatment and the effect of middle molecular toxin removal was compared. Results In the observation group, the effective rate was 93.8%, which was significantly higher than 73.3% in the control group and the difference was statistically significant(χ2=4.77, P0.05). There was a significant decrease in PTH, β2MG, BUN and Scr levels of the two groups after dialytic treatment and the difference was statistically significant (P0.05). After the treatment, PTH, β2MG, BUN and Scr levels of the observation group were significantly lower than those of the control group and the differences were statistically significant(P0.05). Conclusion Continuous renal replacement therapy can effectively remove the middle molecular toxins in patients with uremic encephalopathy, and the clinical eff

文档评论(0)

聚文惠 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档